REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,154,604 | +6.2% | 38,667 | -5.9% | 0.01% | +9.1% |
| Q2 2023 | $5,794,986 | -16.8% | 41,076 | -0.7% | 0.01% | -21.4% |
| Q1 2023 | $6,963,030 | -11.7% | 41,358 | -11.2% | 0.01% | -12.5% |
| Q4 2022 | $7,883,086 | -20.6% | 46,560 | -12.2% | 0.02% | -27.3% |
| Q3 2022 | $9,923,000 | +7.6% | 53,041 | -6.6% | 0.02% | +15.8% |
| Q2 2022 | $9,220,000 | -15.2% | 56,783 | -1.8% | 0.02% | 0.0% |
| Q1 2022 | $10,874,000 | -41.1% | 57,827 | -17.1% | 0.02% | -34.5% |
| Q4 2021 | $18,457,000 | -0.2% | 69,714 | +8.9% | 0.03% | -6.5% |
| Q3 2021 | $18,492,000 | +10.8% | 64,007 | -23.5% | 0.03% | +10.7% |
| Q2 2021 | $16,694,000 | +2.6% | 83,620 | -0.2% | 0.03% | -3.4% |
| Q1 2021 | $16,275,000 | +30.5% | 83,759 | +28.6% | 0.03% | +16.0% |
| Q4 2020 | $12,471,000 | -12.7% | 65,120 | -32.8% | 0.02% | -19.4% |
| Q3 2020 | $14,288,000 | +31.2% | 96,845 | +9.8% | 0.03% | +29.2% |
| Q2 2020 | $10,891,000 | -3.7% | 88,171 | -24.7% | 0.02% | -17.2% |
| Q1 2020 | $11,305,000 | +8.7% | 117,136 | +4.2% | 0.03% | +52.6% |
| Q4 2019 | $10,401,000 | +27.5% | 112,467 | +5.7% | 0.02% | +18.8% |
| Q3 2019 | $8,157,000 | +1.0% | 106,365 | +13.1% | 0.02% | +6.7% |
| Q2 2019 | $8,079,000 | +31.8% | 94,037 | -9.4% | 0.02% | +36.4% |
| Q1 2019 | $6,130,000 | +10.0% | 103,778 | -1.9% | 0.01% | -8.3% |
| Q4 2018 | $5,575,000 | -38.7% | 105,773 | -35.5% | 0.01% | -29.4% |
| Q3 2018 | $9,096,000 | +0.6% | 164,048 | -14.7% | 0.02% | -10.5% |
| Q2 2018 | $9,042,000 | +27.3% | 192,250 | -2.1% | 0.02% | +58.3% |
| Q1 2018 | $7,103,000 | +68.7% | 196,312 | +68.3% | 0.01% | +71.4% |
| Q4 2017 | $4,210,000 | -10.5% | 116,659 | -5.0% | 0.01% | -12.5% |
| Q3 2017 | $4,706,000 | -24.6% | 122,816 | -18.5% | 0.01% | -27.3% |
| Q2 2017 | $6,245,000 | +70.8% | 150,701 | +45.1% | 0.01% | +57.1% |
| Q1 2017 | $3,657,000 | -23.4% | 103,886 | -31.4% | 0.01% | -22.2% |
| Q4 2016 | $4,773,000 | – | 151,496 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |